Columbia Scientists Discover Surprising Link Between Serotonin and Heart Valve Disease

Researchers at Columbia University have identified a significant connection between serotonin and the progression of degenerative mitral regurgitation, a common heart valve disease. The study reveals that patients taking SSRI antidepressants who carry a specific genetic variant may experience accelerated valve damage, potentially requiring surgical intervention at a younger age. This discovery highlights an important interaction between psychiatric medications and cardiovascular health that could have implications for treatment planning. Patients currently taking SSRIs should consult with their healthcare providers about their individual risk factors and monitoring needs. The findings underscore the importance of personalized medicine approaches that consider both genetic predisposition and medication history.